30,000 Intuitive Surgical, Inc. $ISRG Shares Sold by Generate Investment Management Ltd

Generate Investment Management Ltd decreased its position in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 93.3% in the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 2,154 shares of the medical equipment provider’s stock after selling 30,000 shares during the quarter. Generate Investment Management Ltd’s holdings in Intuitive Surgical were worth $876,000 at the end of the most recent reporting period.

Other institutional investors have also modified their holdings of the company. MinichMacGregor Wealth Management LLC raised its holdings in shares of Intuitive Surgical by 24.3% in the 3rd quarter. MinichMacGregor Wealth Management LLC now owns 676 shares of the medical equipment provider’s stock worth $275,000 after purchasing an additional 132 shares in the last quarter. First Citizens Bank & Trust Co. increased its holdings in shares of Intuitive Surgical by 9.2% in the third quarter. First Citizens Bank & Trust Co. now owns 22,884 shares of the medical equipment provider’s stock valued at $9,305,000 after buying an additional 1,920 shares in the last quarter. Focus Financial Network Inc. lifted its position in shares of Intuitive Surgical by 34.1% during the 3rd quarter. Focus Financial Network Inc. now owns 1,976 shares of the medical equipment provider’s stock valued at $804,000 after acquiring an additional 503 shares during the last quarter. Roberts Wealth Advisors LLC lifted its position in shares of Intuitive Surgical by 19.0% during the 3rd quarter. Roberts Wealth Advisors LLC now owns 11,345 shares of the medical equipment provider’s stock valued at $4,613,000 after acquiring an additional 1,809 shares during the last quarter. Finally, Salem Investment Counselors Inc. lifted its position in shares of Intuitive Surgical by 1.2% during the 3rd quarter. Salem Investment Counselors Inc. now owns 64,200 shares of the medical equipment provider’s stock valued at $26,106,000 after acquiring an additional 761 shares during the last quarter. Institutional investors and hedge funds own 83.64% of the company’s stock.

Key Stories Impacting Intuitive Surgical

Here are the key news stories impacting Intuitive Surgical this week:

• Positive Sentiment: UBS reiterated its Buy rating and maintained a $500 price target, citing Intuitive Surgical’s long-term robotic-surgery growth runway. Intuitive Surgical: Buy Rating Reiterated on Long-Term Robotic Growth Runway
• Positive Sentiment: Zacks upgraded ISRG to Rank #2, or Buy, reflecting improving expectations for the company’s earnings outlook. Intuitive Surgical Upgraded to Buy
• Positive Sentiment: Intuitive Surgical is seeking FDA clearance for a next-generation robotic endoscope aimed at gastrointestinal care. Success could expand the company beyond its core surgical market and create a new growth opportunity. ISRG Is Expanding Beyond Surgery
• Positive Sentiment: Erste Group Bank modestly raised its EPS forecasts to $8.94 for fiscal 2026 and $10.09 for fiscal 2027, both above its previous estimates and the current full-year consensus of $8.87.
• Positive Sentiment: Leerink Partners maintained its Buy rating, adding to the constructive analyst commentary surrounding the stock. Leerink Partners Keeps Their Buy Rating

Wall Street Analysts Forecast Growth

ISRG has been the subject of several recent analyst reports. BMO Capital Markets reiterated an “outperform” rating on shares of Intuitive Surgical in a report on Monday, July 20th. UBS Group restated a “buy” rating on shares of Intuitive Surgical in a research report on Tuesday. Stifel Nicolaus reduced their price target on shares of Intuitive Surgical from $670.00 to $550.00 and set a “buy” rating for the company in a research report on Friday, July 17th. Wells Fargo & Company reissued an “overweight” rating and set a $487.00 target price (down from $654.00) on shares of Intuitive Surgical in a research note on Friday, July 17th. Finally, BTIG Research decreased their price target on shares of Intuitive Surgical from $469.00 to $454.00 and set a “buy” rating for the company in a report on Monday. One equities research analyst has rated the stock with a Strong Buy rating, twenty-two have given a Buy rating, seven have given a Hold rating and one has given a Sell rating to the company’s stock. According to data from MarketBeat, the company presently has an average rating of “Moderate Buy” and a consensus target price of $498.83.

Intuitive Surgical Price Performance

Shares of ISRG stock traded down $6.21 on Wednesday, hitting $415.85. The company’s stock had a trading volume of 639,907 shares, compared to its average volume of 2,403,488. The stock has a market capitalization of $146.91 billion, a price-to-earnings ratio of 47.69, a P/E/G ratio of 3.23 and a beta of 1.46. Intuitive Surgical, Inc. has a fifty-two week low of $328.57 and a fifty-two week high of $603.88. The firm’s fifty day moving average price is $388.49 and its 200-day moving average price is $410.14.

Intuitive Surgical (NASDAQ:ISRG) last issued its quarterly earnings data on Thursday, July 16th. The medical equipment provider reported $2.80 earnings per share for the quarter, beating analysts’ consensus estimates of $2.48 by $0.32. Intuitive Surgical had a return on equity of 16.91% and a net margin of 28.45%. The business had revenue of $2.89 billion for the quarter, compared to the consensus estimate of $2.83 billion. During the same period last year, the business earned $1.81 EPS. The firm’s revenue was up 18.4% compared to the same quarter last year. Analysts predict that Intuitive Surgical, Inc. will post 8.87 EPS for the current fiscal year.

Insider Activity at Intuitive Surgical

In other news, EVP Mark Brosius sold 77 shares of Intuitive Surgical stock in a transaction dated Friday, August 21st. The stock was sold at an average price of $375.57, for a total value of $28,918.89. Following the transaction, the executive vice president directly owned 881 shares in the company, valued at approximately $330,877.17. The trade was a 8.04% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is accessible through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, EVP Gary Loeb sold 400 shares of the company’s stock in a transaction that occurred on Monday, August 10th. The stock was sold at an average price of $379.00, for a total value of $151,600.00. Following the transaction, the executive vice president owned 5,320 shares of the company’s stock, valued at approximately $2,016,280. This trade represents a 6.99% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Over the last three months, insiders sold 12,370 shares of company stock valued at $4,891,989. 0.60% of the stock is owned by corporate insiders.

About Intuitive Surgical

Intuitive Surgical, Inc develops and commercializes robotic-assisted systems and related technologies designed to support minimally invasive medical procedures. The company’s products are intended to help surgeons perform operations through small incisions while providing enhanced visualization, precision, and control.

Its principal product is the da Vinci Surgical System, a platform used across a range of specialties, including general surgery, urology, gynecology, thoracic surgery, and cardiac procedures.